UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SAT0134 Mortality and multiple causes of death in rheumatoidarthritis patients. results from a large population-based cohort in the venetoregion, 2010-2015

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.929

2018

Volltextzugriff (PDF)

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate

Annals of the rheumatic diseases, 2003-07, Vol.62 (7), p.686-687

2003

Volltextzugriff (PDF)

AB0286 Assessment of treatment adherence in rheumatoid arthritis italian patients using a validated version of the 5-item compliance questionnaire for rheumatology (I-CQR5)

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1322

2018

Volltextzugriff (PDF)

AB0217 Construct validation of the italian version of the 5-item compliance questionnaire for rheumatology (I-CQR5)

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1292

2018

Volltextzugriff (PDF)

FRI0177 Time To Achieve Remission Predicts Long Term Survival of Low-Dose Etanercept: An Observational Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.493

2016

Volltextzugriff (PDF)

Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept

Annals of the rheumatic diseases, 2005-06, Vol.64 (6), p.899-905

2005

Volltextzugriff (PDF)

FRI0214 Six-Year Retention Rate of Abatacept in Rheumatoid Arthritis: A Multicentric Retrospective Analysis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.509-509

2016

Volltextzugriff (PDF)

FRI0178 Anti-Etanercept Antibodies and Etanercept Leves Levels in Rheumatoid Arthritis Patients Treated with Low and Full-Dose Etanercept in Das28 Remission

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.494

2016

Volltextzugriff (PDF)

SAT0175 Dynamic Automated Synovial Imaging (DASI) for Differentiating between Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.653-654

2014

Volltextzugriff (PDF)

AB0953 A Comparison of Region-Based and Pixel-Based CEUS Kinetics Parameters in the Differentiation of Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1115-1115

2014

Volltextzugriff (PDF)

FRI0154 Low dose etanercept in moderate active rheumatoid arthritis - a pilot study: Induction and maintenance of clinical and radiographic remission

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.363-363

2013

Volltextzugriff (PDF)

FRI0478 Dynamic automated synovial imaging (DASI) For differentiating between rheumatoid arthritis and other forms of arthritis: automated versus manual interpretation in contrast-enhanced ultrasound

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A536-A537

2013

Volltextzugriff (PDF)

AB0716 Update of disease activity assessment in rheumatoid arthritis: comparison between clinical, ultrasound and mri scores and introduction of volumetric inflammation measure concept

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A1006-A1006

2013

Volltextzugriff (PDF)

FRI0477 Validity of contrast-enhanced ultrasound (CEUS) in the detection of synovial inflammation in rheumatoid arthritis compared to power doppler in contrast-enhanced mri controlled pilot study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A536-A536

2013

Volltextzugriff (PDF)

AB0652 INCREASED SERUM ANTI-PTX3 ANTIBODY LEVELS CHARACTERIZE SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS WITH GOOD OUTCOMES

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1612-1612

2024

Volltextzugriff (PDF)

AB1315-HPR HYPERBARIC OXYGEN THERAPY IN FIBROMYALGIA PATIENTS – DOUBLE-BLIND PROSPECTIVE CLINICAL TRIAL

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1947-1948

2020

Volltextzugriff (PDF)

FRI0093 FACTORS ASSOCIATED WITH REFRACTORY RHEUMATOID ARTHRITIS (RRA) ACCORDING TO THREE AVAILABLE DEFINITIONS: TWO CROSS-SECTIONAL ANALYSES IN A LARGE ITALIAN MONOCENTRIC COHORT

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.625-625

2020

Volltextzugriff (PDF)

Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases

Rheumatology (Oxford, England), 2007-06, Vol.46 (6), p.1042-1043

2007

Volltextzugriff (PDF)

Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra

Scandinavian journal of rheumatology, 2007, Vol.36 (3), p.236-237

2007

Volltextzugriff (PDF)

Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases

Autoimmunity reviews, 2005-03, Vol.4 (3), p.162-170

Botsios, Costantino

2005

Volltextzugriff (PDF)

A long-term nationwide study on mortality associated to rheumatoid arthritis in Italy

Clinical and experimental rheumatology, 2020-11, Vol.38 (6), p.1223

2020

Volltextzugriff (PDF)

AB0274 USE OF TNF-INHIBITORS BIOSIMILARS IN CHRONIC INFLAMMATORY ARTHRITIDES: A THREE-YEAR EXPERIENCE IN A LARGE MONOCENTRIC COHORT OF PATIENTS FROM THE NORTH-EAST ITALY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1435-1436

2020

Volltextzugriff (PDF)

Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

Reumatismo, 2011-09, Vol.58 (4), p.268-274

2011

Volltextzugriff (PDF)

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

Reumatismo, 2011-09, Vol.58 (2), p.121-126

2011

Volltextzugriff (PDF)

AB0215 A longer mean survival of biologic treatments is associated with das28 remission in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.1123

2017

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(76)
Berichte
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Male
(25)
Female
(23)
Middle Aged
(22)
Rheumatology
(21)
Adult
(13)
Aged
(13)
Arthritis, Rheumatoid - Drug Therapy
(9)
Rheumatoid Arthritis
(9)
Patients
(8)
Treatment Outcome
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Antirheumatic Agents - Therapeutic Use
(6)
Etanercept
(6)
Follow-Up Studies
(6)
Antirheumatic Agents - Adverse Effects
(5)
Arthritis, Rheumatoid - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

SAT0134 Mortality and multiple causes of death in rheumatoidarthritis patients. results from a large population-based cohort in the venetoregion, 2010-2015

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate

AB0286 Assessment of treatment adherence in rheumatoid arthritis italian patients using a validated version of the 5-item compliance questionnaire for rheumatology (I-CQR5)

AB0217 Construct validation of the italian version of the 5-item compliance questionnaire for rheumatology (I-CQR5)

FRI0177 Time To Achieve Remission Predicts Long Term Survival of Low-Dose Etanercept: An Observational Study

Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept

FRI0214 Six-Year Retention Rate of Abatacept in Rheumatoid Arthritis: A Multicentric Retrospective Analysis

FRI0178 Anti-Etanercept Antibodies and Etanercept Leves Levels in Rheumatoid Arthritis Patients Treated with Low and Full-Dose Etanercept in Das28 Remission

SAT0175 Dynamic Automated Synovial Imaging (DASI) for Differentiating between Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis

AB0953 A Comparison of Region-Based and Pixel-Based CEUS Kinetics Parameters in the Differentiation of Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis

FRI0154 Low dose etanercept in moderate active rheumatoid arthritis - a pilot study: Induction and maintenance of clinical and radiographic remission

FRI0478 Dynamic automated synovial imaging (DASI) For differentiating between rheumatoid arthritis and other forms of arthritis: automated versus manual interpretation in contrast-enhanced ultrasound

AB0716 Update of disease activity assessment in rheumatoid arthritis: comparison between clinical, ultrasound and mri scores and introduction of volumetric inflammation measure concept

FRI0477 Validity of contrast-enhanced ultrasound (CEUS) in the detection of synovial inflammation in rheumatoid arthritis compared to power doppler in contrast-enhanced mri controlled pilot study

AB0652 INCREASED SERUM ANTI-PTX3 ANTIBODY LEVELS CHARACTERIZE SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS WITH GOOD OUTCOMES

AB1315-HPR HYPERBARIC OXYGEN THERAPY IN FIBROMYALGIA PATIENTS – DOUBLE-BLIND PROSPECTIVE CLINICAL TRIAL

FRI0093 FACTORS ASSOCIATED WITH REFRACTORY RHEUMATOID ARTHRITIS (RRA) ACCORDING TO THREE AVAILABLE DEFINITIONS: TWO CROSS-SECTIONAL ANALYSES IN A LARGE ITALIAN MONOCENTRIC COHORT

Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases

Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra

Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases

A long-term nationwide study on mortality associated to rheumatoid arthritis in Italy

AB0274 USE OF TNF-INHIBITORS BIOSIMILARS IN CHRONIC INFLAMMATORY ARTHRITIDES: A THREE-YEAR EXPERIENCE IN A LARGE MONOCENTRIC COHORT OF PATIENTS FROM THE NORTH-EAST ITALY

Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

AB0215 A longer mean survival of biologic treatments is associated with das28 remission in rheumatoid arthritis patients

Suchergebnisse filtern